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Abstract
Human plasma contains naturally occurring autoantibodies to the predominant components of the erythrocyte
membrane: band 3 and spectrin bands 1 and 2 of the cytoskeleton. The titer of cytoskeletal plasma autoantibodies increases
in various hemolytic conditions, suggesting that opsonization of the cytoskeleton may play an important role in the clearance
of hemolyzed (not senescent) erythrocytes from the circulation. In this study, we use Alexa Fluor 488 goat anti-human IgG
conjugate (Molecular Probes, Eugene, OR, USA), to characterize plasma immunoglobulin binding to erythrocyte
membranes from osmotically hemolyzed cells (‘ghosts’). The results show that exposure of ghosts to plasma results in 4-fold
more immunoglobulin binding to the cytoskeleton than is bound to the proteins contained within the lipid bilayer.
Preincubation of the ghosts at 37‡C causes 8-fold more immunoglobulin binding to the cytoskeleton compared to bilayer
proteins. This temperature-induced change resulted from selective immunoglobulin binding to the cytoskeleton, with no
change in immunoglobulin binding to bilayer proteins. However, the rate of increase in cytoskeletal antigenicity at 37‡C did
correlate with the rate of a conformational change in band 3, a transmembrane protein which serves as a major membrane
attachment site for the cytoskeleton. The results of this study suggest that the cytoskeleton is the primary target in the
opsonization of hemolyzed erythrocyte membranes by naturally occurring plasma autoantibodies. The conformational
changes which occur in ghosts at 37‡C are associated with selective exposure of new immunoglobulin binding sites on the
cytoskeleton, and with a change in the structure of band 3. We propose a model suggesting that opsonization of the
cytoskeleton occurs prior to the decomposition of hemolyzed erythrocytes at 37‡C. ß 2001 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Human plasma contains speci¢c IgG autoantibod-
ies against the major components of the erythrocyte
membrane: band 3 (the erythrocyte anion exchanger)
[1,2], and spectrin bands 1 and 2 of the cytoskeleton
[3]. Since intravascular hemolysis results in the re-
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lease of hemoglobin and other cellular components
into the plasma, and is expected to allow plasma
proteins to enter the hemolyzed cell, it is probable
that the cytoskeletal autoimmunity plays a signi¢cant
role in removal of such hemolyzed cells from the
circulation. Yet, most experimental work in the liter-
ature has focused on the mechanism of band 3 anti-
genicity in senescent, intact erythrocytes [4^9], where
cytoskeletal antigenicity would not be an issue. In the
study by Lutz and Wipf [3], an immunoelectropho-
retic method using SDS-solubilized membranes, and
immunoprecipitation of isolated spectrin were used
to characterize binding of naturally occurring auto-
antibodies. There is no information available on the
mechanisms associated with the development of cy-
toskeletal antigenicity within hemolyzed, but other-
wise intact cells. For example, it is not known
whether plasma autoantibodies can even bind to
the cytoskeleton when it is associated with the lipid
bilayer.
In this report, we present the ¢rst experiments
which characterize plasma immunoglobulin binding
to the major membrane components of osmotically
hemolyzed erythrocytes. We have studied the e¡ect
of temperature on plasma immunoglobulin opsoniza-
tion of unsealed human erythrocyte membrane
ghosts using anti-human goat IgG labeled with Alexa
Fluor 488 (IGAF488) (Molecular Probes, Eugene
OR, USA), which reacts with human IgG heavy
chains, and with all classes of human immunoglobu-
lin light chains. The results show that the cytoskele-
ton is the predominant immunoglobulin binding site
on the erythrocyte membrane in hemolyzed cells, and
that the amount of immunoglobulin binding to the
cytoskeleton increases when ghosts are preincubated
at 37‡C. This increase correlates with the conforma-
tional change in band 3 from a transport active to an
inactive form. These results are discussed within the
context of a new model for opsonization and decom-
position of hemolyzed erythrocytes at 37‡C.
2. Materials and methods
2.1. Preparation of unsealed ghosts
Unsealed ghosts were prepared as described previ-
ously [10] with the following speci¢c modi¢cations.
Fresh venous blood was drawn in heparinized tubes
and centrifuged. The plasma was collected and saved
for later use (see below). Forty-¢ve day old packed
erythrocytes were obtained from the Omaha Chapter
of the American Red Cross. O plasma was obtained
from the Blood Bank of the University of Nebraska
Medical Center. Erythrocytes were washed four
times in PBS (5 mM sodium phosphate/150 mM
NaCl (pH 8)) at 4‡C, and the bu¡y coat was re-
moved by aspiration. Stoichiometric labeling of
band 3 in intact erythrocytes by DIDS (4,4P-diiso-
thiocyanatostilbene-2,2P-disulfonic acid) was per-
formed as described previously [10]. Samples were
incubated for 45 min at 37‡C and 50% hematocrit
in PBS (hematocrit is de¢ned in this paper as the
volume of packed cells or ghosts per total sample
volumeU100), or in 25 WM DIDS in PBS. Cells
were washed once in PBS with 0.5% bovine serum
albumin at 4‡C, and then four more times in PBS at
4‡C. Unsealed ghosts were prepared from these
DIDS-labeled, or from unlabeled cells by osmotically
hemolyzing them with a 1/18 dilution in ice cold 5P8
(5 mM sodium phosphate (pH 8)), washing the
ghosts three times in 5P8, and then once in 20P8
(20 mM sodium phosphate (pH 8)), all in a refriger-
ated centrifuge at 4‡C.
2.2. Preparation of resealed ghosts
Resealed ghosts were prepared essentially as de-
scribed previously [10], with the following speci¢c
modi¢cations. Six milliliters of washed erythrocytes
were osmotically hemolyzed 1:5 in ice cold 5P8. The
sample was centrifuged at 4‡C, and the hemolysate
collected. Salts and bu¡er were added to this cold
hemolysate, and this mixture was added back to
the unsealed ghosts to give the following ¢nal con-
centrations: 90 mM sodium sulfate, 5 mM sodium
phosphate, 5 mM Bis-Tris (N,N-bis(2-hydroxyeth-
yl)iminotris(hydroxymethyl)methane), 5 mM Tris
(tris(hydroxymethyl)aminomethane), 1 mM magnesi-
um sulfate, with a ¢nal pH of 7.4. Resealing was
initiated by incubating at 37‡C for 1 h. The resealed
ghosts were then washed in the Bis-Tris/Tris/sulfate
bu¡er three times.
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2.3. Incubation studies with unsealed or resealed
ghosts
2.3.1. Unsealed ghosts
Fifteen milliliter conical tubes were coated with the
protease inhibitors PMSF (phenylmethylsulfonyl £u-
oride), pepstatin A and leupeptin, by adding metha-
nol solutions containing these inhibitors, and evapo-
rating the methanol as described previously [10].
White unsealed ghosts were placed into these pre-
treated tubes and brought to 50% hematocrit with
20P8. The tubes were sealed and placed in the refrig-
erator overnight to inhibit resealing in subsequent
experimental steps [11,12]. The next day, part of
this sample was taken for analysis and designated
as the zero time point. The remainder of the sample
was placed in a tube pretreated with protease inhib-
itors, and then placed in a water bath at 37‡C.
It is known that incubation of ghosts at 37‡C in
low ionic strength bu¡er leads to their breakdown to
vesicles [12,13]. Such breakdown can be minimized
by suspending ghosts in higher ionic strength bu¡er
[13]. We chose to incubate the ghosts in 20P8, which
was high enough in ionic strength to minimize the
breakdown of the ghosts to vesicles, as evidenced by
the fact that the unsealed ghost suspensions could be
completely pelleted by centrifugation at 31 000Ug
for 15 min, to yield typical ‘£u¡y’ white ghosts. In
our experience, a longer centrifugation time (at least
30 min) is required to bring down vesicles using the
same g force.
2.3.2. Resealed ghosts
Resealed ghosts were prepared as described above,
and were placed in a 15 ml conical tube pretreated
with inhibitors as just described. The sample was
stored overnight at 4‡C. The next day, a zero time
point was taken for analysis, with the remainder
placed in the 37‡C water bath.
2.4. Measurement of the extent of sealing during
incubation of pretreated unsealed ghosts at 37‡C
The ability of trypsin to selectively cleave the cy-
toplasmic domain of band 3 [14] was used to mea-
sure the extent of resealing of unsealed ghosts which
had been preincubated overnight at 4‡C, and then
incubated at 37‡C. The assumption in this experi-
ment is that trypsin cleavage of the cytoplasmic do-
main will only occur in unsealed ghosts, and that
inhibition of such cleavage is indicative of ghost re-
sealing. Unsealed ghosts were prepared as described
above, and incubated overnight at 4‡C. They were
then incubated for various lengths of time at 37‡C.
Aliquots were removed, washed in 5P8 at 4‡C to
remove the protease inhibitors, and then treated
with trypsin as described in previous reports
[14,15]. The trypsin reaction was stopped by addition
of 25 Wg/ml of TLCK (NK-p-tosyl-L-lysine chloro-
methyl ketone), plus 1 mM PMSF. The samples
were then washed at 4‡C, and solubilized in SDS
for SDS-PAGE, all as described previously [15].
2.5. Treatment of ghosts with plasma, and labeling
with IGAF488
2.5.1. Unsealed ghosts
Two hundred microliters of unsealed ghosts (50%
hematocrit) were taken either from the samples in-
cubated at 4‡C, or from samples incubated at 37‡C
for various times, and placed in 50 ml centrifuge
tubes. Fifteen milliliters of bu¡er A (10 mM HEPES,
130 mM NaCl, pH 7.4) were added to each tube, and
they were centrifuged at 4‡C, for 15 min at
31 000Ug. This wash was repeated, after which 3.3
ml of plasma was added to each 100 Wl of ghosts
(¢nal hematocrit = 3%). These samples were incu-
bated for 1 h at 37‡C. The tubes were then ¢lled to
35 ml with bu¡er A and centrifuged for 1 h at
31 000Ug and 4‡C. They were then aspirated and
washed two more times in bu¡er A at 4‡C.
IGAF488 was always centrifuged for 4 min at
15 000 rpm in a TOMY MC-150 High Speed Micro-
centrifuge to minimize non-speci¢c binding (Molec-
ular Probes) (also see below). Three hundred micro-
liters of 0.1 WM IGAF488 in bu¡er A were then
added to each 100 Wl of ghosts. Such samples were
then incubated for 2 h at 37‡C, after which the tubes
were ¢lled to 35 ml with bu¡er A and centrifuged at
4‡C. Samples were washed two more times in bu¡er
A at 4‡C. To determine the extent of background
binding of IGAF488, we treated ghosts with
IGAF488 exactly as just described, except that the
plasma treatment step was omitted.
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2.5.2. Resealed ghosts
A 250 Wl sample of resealed ghosts (50% hemato-
crit), incubated as described above, was taken at
each time point, placed in a 50 ml centrifuge tube,
and washed twice in bu¡er A at 4‡C, which main-
tains ghost sealing status. After the last centrifuga-
tion, 3.3 ml of centrifuged plasma was added to 125
Wl of these resealed ghosts. The resealed ghosts were
incubated for 1 h at 37‡C. The 50 ml tube was then
¢lled with bu¡er A, and centrifuged for 1 h at
31 000Ug and 4‡C. They were washed two more
times in bu¡er A with 15 min centrifugation at
31 000Ug and 4‡C. Three hundred microliters of
0.1 WM centrifuged IGAF488 in bu¡er A were added
to each 125 Wl of resealed ghosts. The sample was
incubated for 2 h at 37‡C, after which the tubes were
¢lled to 35 ml with bu¡er A and centrifuged at 4‡C.
The sample was washed two more times in bu¡er A.
Unsealed ghosts were then prepared as described
above.
2.6. Isolation of erythrocyte cytoskeletons
The method used for isolation of cytoskeletons has
been described extensively in the literature [16^20]. It
involves solubilization of ghosts in the non-ionic de-
tergent C12E8 (poly(oxyethylene-8-lauryl ether), fol-
lowed by centrifugation and washing of the pellet,
which contains the cytoskeletons. These washed cy-
toskeletons were then solubilized in SDS in order to
measure total protein (see below), the £uorescence of
IGAF488, and the £uorescence of DIDS-band 3 co-
valent adduct. Speci¢cally, 1.4 ml of ghosts were
brought to 4.2 ml (33% hematocrit) in 20P8 plus
1% C12E8. Then 0.3 ml of these solubilized ghosts
were withdrawn and scanned in the £uorimeter for
IGAF488 and DIDS £uorescence as described above.
The remainder of the preparation was incubated on
ice for 20 min, and then centrifuged for 30 min at
31 000Ug and 4‡C, to pellet the cytoskeletons. The
pellet was gently resuspended in 20 ml of 5P8, and
then centrifuged for 30 min at 31 000Ug and 4‡C.
The supernatant was removed and scanned to estab-
lish the removal of unbound IGAF488. These
washed pellets were then solubilized in 1% SDS in
5P8 (3.9 ml ¢nal total volume), and scanned for
IGAF488 and DIDS-band 3 adduct £uorescence.
Protein absorbance was measured at 280 nm.
2.7. Analytical methods
2.7.1. Fluorescence measurements
Unsealed ghosts (100 Wl) treated with plasma and
IGAF488 were collected and solubilized in a ¢nal
volume of 300 Wl with bu¡er containing 20P8 and
1% C12E8 (¢nal concentrations). These samples
were placed in a £uorescence cuvette with a 10 mm
excitation pathlength and a 4 mm emission path-
length. The £uorescence emission spectrum was mea-
sured at 25‡C using a Perkin-Elmer Model 650-40
£uorescence spectrometer. IGAF488 £uorescence
spectra were collected between 460 and 550 nm,
with the excitation wavelength held at 495 nm. The
£uorescence signal intensity was found to be related
linearly to £uorophore concentration under all con-
ditions. DIDS-band 3 £uorescence spectra were col-
lected between 330 and 500 nm, with the excitation
wavelength set at 350 nm. DIDS £uorescence does
not interfere with IGAF488 £uorescence measure-
ment. Fluorescence data were normalized by measur-
ing the protein absorbance of solubilized samples at
280 nm. An empirical extinction coe⁄cient for solu-
bilized ghosts was determined at this wavelength, us-
ing a stock solution of solubilized ghosts and the
bicinchoninic acid protein assay (Pierce, Rockford,
IL, USA), with a standard curve derived from vari-
ous concentrations of bovine serum albumin. The
280 nm extinction coe⁄cient for solubilized ghosts
was 1.07 ml/mg. Thus, a sample of solubilized ghosts
containing 0.93 mg/ml protein will give an absor-
bance of 1.0 at 280 nm.
2.7.2. Gel ¢ltration chromatography
Gel ¢ltration chromatography was performed es-
sentially as described in previous reports from this
laboratory [10,15] using Sepharose CL-4B as the ma-
trix. The column bu¡er contained 100 mM NaCl,
5 mM sodium phosphate, 0.1% C12E9 (poly(oxyethyl-
ene-9-lauryl ether)) pH 8. Ghosts treated as described
above were washed and pelleted and suspended to
¢nal concentrations of 1% C12E9 and about 2^3
mg/ml of ghost protein. Five hundred microliters of
this sample were then applied to the column. The
absorbance of the column e¥uent was monitored
continuously at 280 nm, using a Pharmacia LKB
UV monitor. The ¢rst 17 ml of e¥uent were col-
lected to establish the e¥uent £ow rate, and there-
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after, 1 ml fractions were collected. Each fraction
was then read for IGAF488 and DIDS-band 3 ad-
duct £uorescence (where indicated). Sample absor-
bance was measured on each tube directly at 280
nm using an Hitachi Model 100-60 spectrophotome-
ter.
2.7.3. Anion transport measurements
Dithionite-sulfate exchange was measured using
the spectrophotometric assay developed in this labo-
ratory as described in a previous report [10]. Veloc-
ities were determined at several dithionite concentra-
tions over a range where the transport data followed
hyperbolic kinetics. The Vmax value was determined,
and the percent change in Vmax plotted versus ghost
preincubation time at 37‡C.
3. Results
3.1. Plasma immunoglobulin binds to unsealed ghosts
to a greater extent than to resealed ghosts, and
incubation at 37‡C increases binding to unsealed
but not to resealed ghosts
We studied immunoglobulin binding to unsealed
and resealed ghosts. In the unsealed ghost experi-
ments, our approach was to hemolyze erythrocytes
osmotically, prepare the ghosts and preincubate them
overnight at 4‡C, in order to inhibit sealing during
subsequent incubation at 37‡C [11,12]. Trypsin cleav-
age studies con¢rmed that the cytoplasmic domain of
band 3 was as accessible to the action of this pro-
tease throughout the 120 h incubation process at
37‡C as it was in the initial preparation of unsealed
ghosts. The gel showed that 100% of the band 3 was
cleaved at each time point studied over the 120 h
incubation period (data submitted for review).
After incubation, the samples were washed, treated
with plasma, and then treated with IGAF488, as
described in Section 2. Experiments were performed
with either fresh erythrocytes and autologous plasma
(n = 7), or with 45 day old erythrocytes (n = 2), and
non-autologous plasma from an O individual.
There was no signi¢cant di¡erence in the results ob-
tained with fresh versus 45 day old red cells, or from
the use of autologous versus non-autologous plasma.
Fig. 1 shows normalized £uorescence spectra of
various ghost samples after solubilization in 20P8
plus 1% C12E8. Unsealed ghosts which were not
treated with plasma or IGAF488 gave no £uores-
cence peak between 550 nm and 505 nm (spectra 1
in Fig. 1A,B). The large increase in the signal below
500 nm in Fig. 1 (curve 1) is due to the breakthrough
from the excitation source.
Treatment of unsealed ghosts with plasma fol-
lowed by IGAF488 yielded a £uorescence spectrum
for detergent solubilized ghosts which had a peak
centered around 515 nm (Fig. 1A, spectrum 2).
Treatment with IGAF488 alone (no plasma treat-
ment step) gave a background binding which was
about 3^5-fold smaller than that seen for spectrum
2 in Fig. 1A (not shown, but see the discussion of
Fig. 2 below). Incubation of unsealed ghosts at 37‡C
for 120 h increased the amount of IGAF488 bound
per mg of total ghost protein by 2.5-fold (compare
spectra 2 and 3 in Fig. 1A). Electrophoresis of the
samples showed that the incubation under our con-
ditions in the presence of protease inhibitors caused
no signi¢cant change in the classical pattern for Coo-
massie blue stained SDS-PAGE gels of unsealed
ghosts [16] (data not shown).
Fig. 1B illustrates that when the same unsealed
ghost preparations were incubated for 120 h at
4‡C, no increase in immunoglobulin binding was ob-
served (compare spectrum 2 to spectrum 3 in Fig.
1B). Keep in mind that the immunoglobulin binding
assay (i.e. the plasma and IGAF488 treatment steps)
was always performed under exactly the same con-
ditions for the various experiments shown in Fig.
1A,B (see Section 2). Thus, increased immunoglobu-
lin binding to unsealed ghosts is dependent on the
temperature experienced by the ghosts prior to being
exposed to plasma and IGAF488.
An important question is whether increased immu-
noglobulin binding involves sites on the outside, or
on the inside of the ghosts. Fig. 1C shows the results
from studies with resealed ghosts incubated at 37‡C.
In this case, the resealed ghosts were incubated for
144 h, and then treated with plasma and IGAF488.
Resealed ghosts showed no increase in immunoglob-
ulin binding after 144 h (Fig. 1C, compare spectrum
2 to spectrum 3). In addition, the initial amount of
IGAF488 bound per mg of ghost protein was sub-
stantially less than that seen when unsealed ghosts
were treated with plasma and IGAF488 (compare
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the spectra labeled 2 in Fig. 1A^C). However, the
£uorescence intensity around the IGAF488 peak
was greater for resealed ghosts treated with plasma
and IGAF488 than for ghosts which had not been
exposed to plasma or IGAF488. Thus, plasma im-
munoglobulin binding sites do exist on the outer sur-
face of ghosts (also see below). Substantially more
sites exist on the inner surface of the ghosts (under
the same plasma treatment conditions), and the in-
crease in immunoglobulin binding to unsealed ghosts
upon incubation at 37‡C involves sites at the inner
surface of the membrane.
3.2. The erythrocyte cytoskeleton is the predominant
plasma immunoglobulin binding site on the
cytoplasmic surface of unsealed ghosts
The cytosolic side of unsealed ghosts contains two
potential immunoglobulin binding sites which exist
in su⁄cient quantity to explain our observations.
One of these sites is the cytoplasmic domain of
band 3, while the other is the cytoskeleton. We
used classical means to separate the cytoskeleton
from the major components contained within the lip-
id bilayer, i.e. solubilization of the ghosts in non-
ionic detergent at relatively high ionic strength
(20P8), followed by centrifugation, removal of the
supernatant and washing of the pellet [17^20]. The
ghosts were derived from erythrocytes which were
labeled with DIDS (a covalent, band 3-speci¢c anion
transport inhibitor), so that we could follow the dis-
position of band 3 in subsequent gel ¢ltration stud-
ies.
Background IGAF488 binding to unsealed ghosts
not exposed to plasma (Fig. 2, M Initial (3) plasma)
was 5-fold lower than IGAF488 binding to ghosts
which were pretreated with plasma (Fig. 2, M Initial
(+) plasma). Such background binding of IGAF488
to untreated ghosts was found to be located ex-
clusively on the components contained within the
Fig. 1. Fluorescence spectra of solubilized unsealed ghosts incubated at either 4‡C, or 37‡C, or of resealed ghosts incubated at 37‡C,
and then opsonized with plasma immunoglobulin and IGAF488. Ghosts were treated as described below, and then solubilized in 20P8
plus 1% C12E8, as described in Section 2. The £uorescence spectra were collected at 25‡C (Vexcite = 495 nm) as continuous traces on a
strip chart recorder. The data points were read from the traces and each spectrum was normalized by dividing by the total protein
concentration for the given sample. Total protein was determined by measuring the absorbance at 280 nm, and using an experimen-
tally determined extinction coe⁄cient for total ghost protein (see Section 2 for further details). (A) Unsealed ghosts incubated at
37‡C. Spectra: 1, initial unsealed ghost sample, no plasma or IGAF488 added; 2, initial unsealed ghost sample treated with plasma
and IGAF488; 3, unsealed ghosts incubated for 120 h at 37‡C, and then treated with plasma and IGAF488. (B) Unsealed ghosts in-
cubated at 4‡C. Spectra: 1, initial unsealed ghost sample with no added plasma or IGAF488; 2, initial unsealed ghost sample treated
with plasma and IGAF488; 3, unsealed ghosts incubated for 120 h at 4‡C, and then treated with plasma and IGAF488. (C) Resealed
ghosts incubated at 37‡C. Spectra: 1, no added plasma or IGAF488; 2, initial resealed ghosts treated with plasma and IGAF488;
3, resealed ghosts incubated at 37‡C for 144 h, and then treated with plasma and IGAF488. The large peak (V6 500 nm) in all of the
panels is the breakthrough from the excitation source at 495 nm.
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detergent-soluble membrane fraction of ghosts (Fig.
2, S Initial (3) plasma). The pellet fraction from
ghosts treated with IGAF488 alone (Fig. 2, P Initial
(3) plasma) had no detectable IGAF488 bound com-
pared to untreated controls (also see Fig. 4B below).
While pretreatment with plasma caused a slight in-
crease in IGAF488 binding within the solubilized
membrane fraction (Fig. 2, S Initial (+) plasma ver-
sus S Initial (3) plasma), there was a 20-fold increase
in the amount of bound IGAF488 within the pellet
fraction (Fig. 2, P Initial (3) plasma versus P Initial
(+) plasma).
Incubation of ghosts at 37‡C for 120 h, followed
by treatment with plasma and IGAF488, caused an
approx. 2-fold increase in IGAF488 binding to mem-
branes as compared to initial unsealed ghosts (Fig. 2,
M Initial (+) plasma versus M 120 h (+) plasma).
This result was not signi¢cantly di¡erent from that
seen for unsealed DIDS-free ghosts (Fig. 1A, spec-
trum 2 versus spectrum 3). The increased immuno-
globulin binding after incubating for 120 h at 37‡C is
almost exclusively due to immunoglobulin binding to
the cytoskeletal pellet (Fig. 2, compare 120 h (+)
plasma, P versus S). It should be noted that the
cytoskeletons so generated were free of band 3 on
the basis of DIDS £uorescence measurements, and
that they contained spectrin and actin as predomi-
nant Coomassie blue staining bands on SDS-PAGE
(data not shown).
We next analyzed band 3 in the solubilized ghosts
by analytical gel ¢ltration chromatography [8,10,15]
to see if immunoglobulin binding to band 3 changes
during incubation, and to determine if the aggrega-
tion state of band 3 changes. Fig. 3 shows chromato-
graphic pro¢les for a sample of membranes after in-
cubation for 120 h at 37‡C, and for a sample of the
same membranes without incubation. The elution
pro¢les using DIDS £uorescence (top panels in Fig.
3) indicate the position of band 3. There was no
DIDS £uorescence in the void volume for either
the initial or the 120 h incubated samples, indicating
that band 3 maintained its dimeric/tetrameric state
over this time period, and did not aggregate to high-
er oligomers, or dissociate to monomers, in agree-
ment with our previous studies [10].
The lower panels in Fig. 3 show the corresponding
pro¢les for protein concentration (closed circles), and
for IGAF488 (Alexa) £uorescence (open circles). Gel
Fig. 2. Normalized ratios of bound IGAF488 (£uorescence/pro-
tein) for solubilized DIDS-labeled unsealed ghosts (M), for the
washed, solubilized cytoskeletal pellet (P), and for the superna-
tant fraction (S). Unsealed ghosts from initial samples or from
samples incubated for 120 h at 37‡C were either treated or not
treated with plasma, and then all samples were treated with
IGAF488 as described in Section 2. These samples were solubi-
lized in 20P8 plus 1% C12E8. Part of the sample was saved as
the total membrane sample for each experimental condition
(M). The remainder of each sample was centrifuged and the
supernatant fraction (S) was removed. The pellet (P) was
washed once in 5P8 and saved. All three types of samples (M,
P, S) were analyzed by SDS-PAGE, by measuring the £uores-
cence of IGAF488, and by measuring the protein absorbance at
280 nm, as described in Section 2. The normalized ratios of
IGAF488 £uorescence/[protein] were calculated by ¢rst deter-
mining the absolute £uorescence/[protein] ratio for a given sam-
ple as in Fig. 1, and then dividing that ratio by the ratio for M
Initial (3) plasma. IGAF488 binding is observed for the initial
sample and is con¢ned entirely to the supernatant fraction,
with no detectable £uorescence in the cytoskeletal fraction com-
pared to background (no additions). Pretreatment of ghosts
with plasma caused a 5-fold increase in IGAF488 binding to
the ghosts (M initial (3) versus (+) plasma) which is due to in-
creased binding to the cytoskeleton. Incubation of ghosts for
120 h at 37‡C caused a slight increase in IGAF488 binding in
the absence of plasma (see Fig. 4B), but caused a 2-fold in-
crease in IGAF488 binding to ghosts (M initial (+) plasma ver-
sus M 120 h (+) plasma). This increased binding with tempera-
ture and time occurs predominantly due to immunoglobulin
(IGAF488) binding to the cytoskeleton.
BBAMEM 78056 1-3-01
J.M. Salhany et al. / Biochimica et Biophysica Acta 1511 (2001) 168^180174
electrophoresis (not shown) indicated the presence of
certain cytoskeletal proteins in the void volume, but
no band 3, in agreement with the DIDS £uorescence
pro¢le. Band 3 (Coomassie blue staining) and glyco-
phorin A (periodic acid Schi¡’s base staining) were
observed in the main peak of the included volume.
Glycophorin A was present in the trailing edge of the
peak, while band 3 was present across the peak, but
most prominently in the leading edge and at the peak
position.
In order to quantitate changes in immunoglobulin
binding to band 3, we measured the integrated peak
area of the DIDS £uorescence pro¢le and the peak
area of the IGAF488 £uorescence pro¢le. The ratio
of IGAF488 to DIDS £uorescence was 0.27 for the
initial sample in Fig. 3. It was 0.25 for the same
preparation of membranes after incubation for 120
h at 37‡C. While the ratios for band 3 were not
signi¢cantly di¡erent, there was an increase in the
ratio of IGAF488 £uorescence to protein for the
material in the void volume, which contained cyto-
skeletal proteins, but no band 3.
3.3. Correlation of the kinetics of band 3
conformational changes with the kinetics of
increased immunoglobulin binding to the
cytoskeleton
While incubation of ghosts at 37‡C does not pro-
mote increased binding of plasma immunoglobulins
to band 3, we had shown previously that the mem-
brane domain of band 3 does undergo a conforma-
tional change over this time range when incubated at
37‡C [10]. Since band 3 is a major attachment site for
the cytoskeleton, we investigated whether there was a
correlation at 37‡C between the rate of increase in
Fig. 3. Gel ¢ltration chromatography of initial, and 120 h, 37‡C incubated unsealed ghost samples, treated with plasma and
IGAF488, and then solubilized in non-ionic detergent. Ghosts from DIDS-labeled erythrocytes were prepared, and an initial sample
taken. The remainder of the material was incubated for 120 h at 37‡C as described in Section 2. Both sets of ghosts were treated with
plasma and IGAF488, solubilized in C12E8, and these solubilized samples applied to a CL-4B column as described in Section 2. Tubes
were collected and analyzed for protein absorbance at 280 nm, IGAF488 £uorescence, and DIDS £uorescence.
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immunoglobulin binding to the cytoskeleton and the
rate of change in band 3 from the transport-active to
the less active form [10]. The incubation conditions
used here were not exactly the same as in our pre-
vious study (i.e. there was no dithiothreitol used
here), so we elected to measure the rate of band 3
conformational change under the present conditions,
using a transport assay [10], and to correlate this
with kinetic measurements of the increase in immu-
noglobulin binding to unsealed ghosts incubated for
various times at 37‡C. Resealed ghosts were used to
measure anion transport. In separate experiments,
the spectral shift in DIDS-band 3 £uorescence [10]
was also measured under our present conditions.
The kinetics of the increase in immunoglobulin
binding to unsealed ghosts incubated at 37‡C were
studied at various times. Fig. 4A shows that the im-
munoglobulin binding capacity increases by about
2.5-fold, to an apparent end point, following an ex-
ponential time course with an apparent rate constant
of 0.012 h31 (see legend to Fig. 4). Fig. 4B indicates
that incubation of ghosts at 37‡C promotes only
about a 30% increase in binding of IGAF488 to un-
sealed ghosts incubated for various times at 37‡C,
when the plasma treatment step is omitted. We saw
in Fig. 2 that plasma-independent IGAF488 binding
occurs exclusively to components in the membrane
domain.
Fig. 5A shows a plot of the percent of initial trans-
port Vmax remaining (i.e. 100U(Vmax/(Vmax)initial)) for
resealed ghosts as a function of incubation time
(open squares) versus the percent of remaining im-
munoglobulin binding sites (closed circles). The data
for immunoglobulin binding were taken from Fig.
4A. The number of immunoglobulin binding sites
increases with time (Fig. 4A). In Fig. 5A we plot
the percent of immunoglobulin binding sites remain-
ing in a given sample, which was calculated using the
estimated value for the maximum in immunoglobulin
binding from the ¢t in Fig. 4A as the 100% value (see
legend to Fig. 5). The loss of transport activity oc-
curs at a rate which is similar to the rate of appear-
ance of new immunoglobulin binding sites on the
Fig. 5. Correlation of band 3 conformational changes with plas-
ma immunoglobulin binding. (A) Plot of the loss in transport
activity of resealed ghosts (100U(Vmax/(Vmax)initial)) (E) as one
measure of band 3 conformation [10], and of the percent re-
maining immunoglobulin binding sites present in unsealed
ghosts (b). Percent remaining immunoglobulin binding sites
was calculated from the data in Fig. 4A as 100U(F3Fr/
F03Fr), where F is de¢ned as in Fig. 4. The curve through the
data is drawn on the basis of an exponential ¢t to the immuno-
globulin binding data of Fig. 4A. (B) Fluorescence spectra of
DIDS-labeled membranes derived from initial ghosts, or from
ghosts incubated for 120 h at 37‡C, and solubilized in C12E8.
Fig. 4. Kinetics of increase in plasma immunoglobulin binding
to unsealed ghosts incubated at 37‡C. Unsealed ghosts were in-
cubated at 37‡C, and samples taken at various times. Samples
were split into three portions and treated: (A) with plasma and
IGAF488 (b) ; (B) with no additions (a), or with IGAF488
alone (F). IGAF488 £uorescence and protein absorbance were
determined on the solubilized treated samples as described in
Fig. 1. The points are independent determinations. The data in
A were ¢t to a single exponential function of the form:
F = Fr(13e3kt)+F0(e3kt), where F is the ratio of £uorescence, at
515 nm, to protein concentration, and k is the apparent rate
constant. We obtained values of F0 = 1.24 þ 0.63 ml/mg,
Fr = 4.6 þ 2.01 ml/mg, and k = 0.012 þ 0.01 h31. The curve in A
indicates the ¢t. The lines in B are ¢ts to a linear function.
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cytoskeleton of unsealed ghosts. The time course for
the loss in transport activity seen in Fig. 5A is com-
parable ( þ factor of 2) to that published previously
[10] for ghosts incubated at 37‡C, but performed
under slightly di¡erent experimental conditions (see
Section 2).
In Fig. 5B we see a shift in the £uorescence spec-
trum of the DIDS-band 3 after incubation of DIDS-
labeled ghosts for 120 h at 37‡C. This spectral shift is
indicative of a change in the conformation of the
band 3 membrane domain, in agreement with pre-
vious ¢ndings under somewhat di¡erent bu¡er con-
ditions [10]. Taken together, these results establish
that a conformational change occurs in the mem-
brane domain of band 3 at 37‡C, which correlates
with the conformational change in unsealed ghosts
associated with a selective increase in plasma immu-
noglobulin binding to the cytoskeleton.
4. Discussion
The experiments presented in this paper were de-
signed to characterize immunoglobulin binding to
membranes from hemolyzed erythrocytes as a func-
tion of time and the temperature present during the
ghosts’ preincubation period. The plasma immuno-
globulin binding assay was performed under exactly
the same experimental conditions for all of the sam-
ples studied. Thus, any changes in immunoglobulin
binding capacity re£ect a change in the structure of
the membrane. The results indicate: (a) that the cy-
toskeleton is the predominant binding site for natu-
rally occurring autoantibodies present in plasma;
(b) that incubation of ghosts at 37‡C increases
immunoglobulin binding to the cytoskeleton by
2.5-fold, without increasing binding to band 3 or to
the other major components contained within the
Fig. 6. Schematic model for the in vivo opsonization and decomposition of the hemolyzed human erythrocyte at 37‡C. This schematic
shows: (1) the hemolysis of a single erythrocyte, and the release of hemoglobin (Hb) and the entrance of plasma immunoglobulin
(Ig); (2) the conformational change in band 3 (B) from native (perpendicular to the surface of the membrane) to the transport inactive
form (bent conformation), and the increase in binding of immunoglobulin to the cytoskeleton, combined with migration of band 3
into budding bilayer vesicles ; which leads to (3) the ¢nal product, consisting of a ‘stripped’, immunoglobulin saturated cytoskeleton,
and cytoskeleton-free membrane vesicles. See text for further details.
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lipid bilayer; and (c) that this increase in immuno-
globulin binding occurs at a rate which is similar
to the rate of conformational change in band 3, a
major cytoskeletal attachment site within the lipid
bilayer.
Comparison of the results in Fig. 1A,C shows that
incubation of ghosts at 37‡C leads to a large increase
in immunoglobulin binding to the inner surface of
the erythrocyte membrane (Fig. 1A), without increas-
ing binding at the outer surface (Fig. 1C). The outer
membrane surface is probably responsible for the
background IGAF488 binding, since Alexa 488 £uo-
rescence is seen in the supernatant fraction, but not
in the pellet after solubilization in non-ionic deter-
gent (Fig. 2, Initial (3) plasma). The components of
the lipid bilayer which bind background IGAF488
would have interacted with immunoglobulins in
vivo, since most of these membrane elements are
transmembrane proteins which are exposed to plas-
ma (e.g, band 3). The fact that background IGAF488
binding (no plasma pretreatment) occurs to compo-
nents contained within the membrane bilayer only,
and not to the cytoskeleton (Fig. 2), is consistent
with our use of IGAF488 as a speci¢c probe of mem-
brane-bound immunoglobulins.
Treatment of ghosts with plasma speci¢cally in-
creases IGAF488 binding to the cytoskeleton, with-
out signi¢cantly increasing the amount of probe
bound in the solubilized lipid bilayer fraction (Fig.
2, Initial (3) versus (+) plasma). Incubation at 37‡C
substantially increases speci¢c opsonization of the
cytoskeleton while it remained associated with the
bilayer in unsealed ghosts (Fig. 2, 120 h (+) plasma).
There was no evidence for band 3 aggregation under
our experimental conditions as indicated by the total
absence of DIDS £uorescence in the void volume of
the column in Fig. 3. SDS-PAGE analysis con¢rmed
the DIDS £uorescence measurements by indicating
the absence of band 3 in the void volume of the
column.
The observation, in Fig. 2, of increased immuno-
globulin binding to the cytoskeleton after incubation
of ghosts at 37‡C implies that some type of confor-
mational change occurs in ghosts, which exposes
autoantibody binding sites on the cytoskeleton.
Although this change could be localized to spectrin
molecules within the cytoskeleton, the evidence indi-
cates that the entire membrane may be involved in
the conformational change which leads to exposure
of new cytoskeletal immunoglobulin binding sites.
We found that the rate of exposure of cytoskeletal
binding sites and the rate of change in the conforma-
tion of the membrane domain of band 3 were the
same (Fig. 5A). Band 3 is a major cytoskeletal at-
tachment site through binding of the connecting pro-
tein known as ankyrin [21]. While further experi-
ments are needed, it is not unreasonable to suppose
that the conformational change in the membrane do-
main of band 3 and the increase in the number of
immunoglobulin binding sites on the cytoskeleton
are linked. For example, there is clear and ample
evidence in the literature that the conformation of
the membrane domain of band 3 can in£uence bind-
ing events at the cytoplasmic domain [22,23]. In ad-
dition, several laboratories have shown that the con-
formational stability of the membrane domain is
signi¢cantly in£uenced by attachment of the cyto-
plasmic domain [24,25].
We summarize our results schematically in Fig. 6,
within the context of a plausible in vivo model for
opsonization of hemolyzed human erythrocytes at
37‡C. Fig. 6 shows an intact erythrocyte with
band 3 in the native conformation, exposed to the
outer surface of the lipid bilayer. The cytoskeleton is
labeled with black dots to distinguish it from the
bilayer. In step 1, plasma immunoglobulin would
gain access to the interior of the cell after an intra-
vascular hemolytic episode, where hemoglobin is re-
leased into the plasma and plasma proteins enter the
cell. This would lead to initial binding of immuno-
globulin to cytoskeletal sites as demonstrated by our
results (Figs. 1 and 2). Because this is an in vivo
schematic model, we would expect the ghosts to
reseal at the physiological salt concentration present
in blood [12]. Thus, we show a sealed spherical
ghost between steps 2 and 3 in Fig. 6. In our in
vitro experiments, ghost resealing was inhibited
(see Section 3) in order to allow for quantitation
of immunoglobulin binding at the inner surface of
the membrane. In step 2 of Fig. 6, band 3 undergoes
a conformational change at 37‡C [10], which is cor-
related in time with exposure of additional immuno-
globulin binding sites on the cytoskeleton (Fig. 5A).
While the exact mechanism for linking these two
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changes is not established, testable possibilities can
be suggested. The conformational change in band 3
(Fig. 5) could allow it to be more mobile in the plane
of the lipid bilayer, consequent to a diminished in-
teraction of the cytoplasmic domain of band 3 with
the cytoskeleton [26]. The cytoskeleton could be par-
tially displaced from proximity with the lipid bilayer,
which may allow for increased immunoglobulin
binding. Such changes could promote the budding
of cytoskeleton-free membrane vesicles ([26] and
Fig. 6). Evidence in the literature indicates a role
for membrane vesicle shedding in erythrocyte ho-
meostasis [27], and it has been suggested that band
3-lipid interactions play a signi¢cant role in such a
vesiculation process [28]. We envision that over time,
this vesiculation process leads to a cytoskeleton
which is both ‘stripped’ of bilayer and heavily opson-
ized by immunoglobulin molecules (Fig. 2).
Our results seem most relevant to conditions in-
volving intravascular hemolysis [29]. Numerous con-
ditions can cause intravascular hemolysis, such as
microangiopathic hemolytic anemia, associated with
thrombotic thrombocytopenic purpura. In this latter
condition, there is clear evidence for red cell frag-
mentation which is thought to arise from the inter-
action of the red cell with ¢brin strands in the par-
tially thrombosed microvasculature. Microangio-
pathic hemolytic anemia is observed in several multi-
system disorders that also a¡ect the kidney, including
malignant hyperthermia, renal cortical necrosis and
other conditions. Patients with systemic lupus eryth-
ematosus can have a thrombotic microangiopathic
syndrome that includes microangiopathic hemolytic
anemia [29]. Fragmentation hemolysis has been
found after replacement of aortic and mitral valves
with prosthetic devices. Finally, various chemical and
physical agents can produce intravascular hemolysis
[29]. Serum immunoglobulin binding to the cytoskel-
eton may be expected to occur in these various con-
ditions.
In summary, the results of this paper establish that
the cytoskeleton is the predominant target for plas-
ma immunoglobulin binding to hemolyzed, but oth-
erwise intact human erythrocyte membranes. We
suggest that cytoskeletal opsonization occurs as an
initial step in the removal of hemolyzed erythrocytes
from the circulation.
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